Gynecologic Cancer
From the Journals
Obesity increasing the risk for cancer: It’s complicated
For some cancers it was “very clear that obesity increased the risk ... but for some other cancer types, we either don’t have enough data yet or...
Conference Coverage
Symptoms, not pelvic exams, pick up most endometrial cancer recurrences
The findings speak to the anxiety of shifting to telemedicine during COVID-19.
Conference Coverage
Complex surgery 10 times more likely with some ovarian tumors
Imaging, tumor subtype predict debulking success in advanced ovarian cancer.
Clinical Review
2022 Update on gynecologic cancer
Highlights from 4 medical and surgical trials on gynecologic cancers and what their results may mean for patient-focused outcomes...
Gynecologic Oncology Consult
The medical management of early-stage endometrial cancer: When surgery isn’t possible, or desired
Hormonal therapy has long been identified as a highly effective systemic therapy for endometrial cancers, particularly those that are low grade...
From the Journals
Virtual exams for routine surveillance after ovarian cancer
The pandemic has accelerated the use of telemedicine. The investigators wondered how it would work in patients who have achieved remission from...
Latest News
Researchers identify growing racial disparity in endometrial cancer mortality
The 5-year relative survival rate for Black women is 63%, compared with 84% for White women – a 21% gap in absolute terms.
Gynecologic Oncology Consult
Optimizing ‘optimal’ in ovarian cancer cytoreduction
While pafolacianine promises to move us closer to a true “R0” (negative margins) resection of ovarian cancer, is this even a feasible goal in a...
Latest News
Cervical cancer screening rates on the decline in the U.S.
New research finds that cervical cancer screening rates in the United States have fallen over the last 14 years and that lack of patient education...
Latest News
Symptoms common in high-risk, early-stage ovarian cancer
More than 70% had at least one symptom such as abdominal/pelvic pain or increased girth/fullness.
From the Journals
HPV testing plus cytology catches two times more cervical lesions
Research suggesets that hrHPV testing is the “best strategy for a timely diagnosis of CIN2+ lesions while avoiding overtreatment” of young women...